MindMed Added To The Russell 3000 and The MSCI Canada Index [Where Does MNMD/MMED Go From Here?]

MindMed (NASDAQ: MNMD), (MMED: NEO) has been added to two major indexes; the Russell 3000 and the Morgan Stanley Capital International Canada Index.
In this segment we will explain what that means and how this news will influence the stock price.

Links:
MindMed (MMED / MNMD) added to the Russell 3000:

[deleted by user]
by inMindMedInvestorsClub

Big news: MindMed has been added to one of the main US stock market indices (Russell 3000) and will soon be in Vanguard/iShares/other ETFs and institutional portfolios tracking this index
byu/curvedcorners inMindMedInvestorsClub

MindMed added to the MSCI Canada Index:
https://financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/neo-exchange-announces-eligibility-in-msci-indexes

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌

Instagram: @thepsychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
Video editing: @themyaholy
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

#MindMed #MNMD #MindmedNews

Psychedelic Spotlight

Examining Ketamine Therapy with Myriam Barthes, Journey Clinical

June 15, 2022June 2, 2024 Listen, Podcasts

In today’s episode, Myriam describes the impact of ketamine on the mind and the body, and specifically how ketamine therapy compares to other psychedelic-assisted therapies.

The Spotlight Round Up Video, April 14th

April 14, 2021June 2, 2024 Listen, Psychedelic Spotlight Videos

In this week’s episode of The Spotlight Roundup, we check in with the Fireside Project, the first-ever 24/7 psychedelic peer support line; the State of Oregon forms an advisory board to oversee the implementation of psilocybin use in specialized clinics; and The American Journal of Psychiatry publishes new guidance on how to safety and effectively use Ketamine and Esketamine.

Welcome to Plant Medicine Week, by Microdose. Join the Psychedelic Revolution

March 17, 2022June 2, 2024 Listen, Videos

Buy tickets for Plant Medicine Week in Malta, April 5th-8th by using our promo link: https://tickets.plantmedicineweek.com/attendance/event/index/41436/EN?promocodes=PSYC

Get 50% off tickets via the link above or by inputting code PSYC at the checkout over at plantmedicineweek.com/tickets!

Do you both love learning about psychedelics, and need a vacation in beautiful Malta? Well you are in luck, because Microdose.buzz is hosting a one of a kind event next month.

To learn more about the emerging psychedelic industry, visit:
https://psychedelicspotlight.com/

At the event you will be able to learn about the medical benefits, research, and business of psychedelics, as well as marijuana. The all-star studded line-up includes representatives from companies such as atai Life Sciences (ATAI), Awakn Life Sciences (AWKN, AWKNF) and more.

From panels on psychedelics and sex, to how to make money investing in psychedelics, this event will have it all. Plus…AFTER PARTIES!

No matter if you want to learn about LSD, MDMA, psilocybin, ketamine or more, this event will have it all. We already know that psychedelics can help with mental health, now hear it first hand from the scientists themselves.

#Psychedelics #MentalHealth #Microdose

Interview With Joshua Bartch

April 28, 2021June 2, 2024 Listen, Podcasts

Mydecine Innovations Group’s Director, CEO & Co-Founder, Joshua Bartch chats with our Director of Content, Jill Ettinger.

MindMed gets FANTASTIC News from the FDA, Causing its Stock to Skyrocket (MNMD/MMED) | Project Lucy

January 26, 2022June 2, 2024 Listen, Videos

To learn more about the emerging psychedelic industry, visit:
https://psychedelicspotlight.com/

MindMed (Nasdaq: MNMD, NEO: MMED) today announced that their Flagship Program, Project Lucy, has been given the green light from the FDA. MindMed is set to start a phase 2b Clinical Trial treating Generalized Anxiety Disorder with MM-102.
In response, MindMed’s stock has SKYROCKETED! It is up 39% at the time of writing and it could go higher. The psychedelic stock has been battered over the last 8 months, so it is good to see positive news affecting the price.
MindMed is a company attempting to treat mental health conditions such as Anxiety and Depression with Psychedelic Therapies.
Can psychedelics relieve anxiety and treat mental health? MindMed wants to know!

#MNMDstock# MindMed #Psychedelics

Changing Lives Through Psychedelic-Assisted Therapy – Healing Souls

January 25, 2023June 2, 2024 Listen, Podcasts

In today’s episode, we talk with Dr. Ryan Westrum, the founder and visionary of Healing Souls, a practice dedicated to changing the way individuals, couples and families look at counseling.